Synthesis of new OBAN's and further studies on positioning of the catalytic group
- 7 June 2004
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 2 (13), 1901-1907
- https://doi.org/10.1039/b403652b
Abstract
Two new zinc ion dependent oligonucleotide based artificial nucleases (OBAN's) have been synthesized. These consist of 2′-O-methyl modified RNA oligomers conjugated to 5-amino-2,9-dimethylphenanthroline (neocuproine) via a urea linker. OBAN 4 carries the catalytic group on a linker extending from the C-4 of an internal cytosine moiety. OBAN 5 has two neocuproine units attached, each to linkers extending from the C-5 position of uridine moieties, one placed internally and the other at the at the 5′-end of the oligonucleotide. The key step in the synthesis of the OBAN systems is conjugation of the catalytic group to the respective amino linkers of the modified oligonucleotides. This is achieved by first converting the 5-amino-2,9-dimethylphenanthroline to the phenylcarbamate. The reaction of this neocuproine phenylcarbamate with the oligonucleotide carrying one or two primary aliphatic amines in aqueous buffer (at pH 8.5) leads to nearly quantitative formation of the urea-linked conjugates. Both OBAN systems were found to cleave RNA in the bulged out regions formed from the non-complementary part of the target sequences, in the presence of Zn(II) ions. Differences in efficiency between these and previously reported systems are discussed.Keywords
This publication has 39 references indexed in Scilit:
- Chemical nucleasesCurrent Opinion in Chemical Biology, 2001
- Antisense therapeutics: lessons from early clinical trialsCurrent Opinion in Oncology, 2001
- Antisense therapy in oncology: new hope for an old idea?The Lancet, 2001
- Sequence-Selective Artificial RibonucleasesMethods in enzymology, 2001
- Synthetic oligonucleotides as therapeutics: The coming of ageBiotechnology Annual Review, 2000
- Antisense therapeuticsCurrent Opinion in Chemical Biology, 1998
- Inorganic Mimics of Ribonucleases and Ribozymes: From Random Cleavage to Sequence-Specific Chemistry to Catalytic Antisense DrugsChemical Reviews, 1998
- Antisense TherapeuticsBiotechnology and Genetic Engineering Reviews, 1998
- The ups and downs of nucleic acid duplex stability: structure-stability studies on chemically-modified DNA:RNA duplexesNucleic Acids Research, 1997
- Progress in antisense therapeuticsMedicinal Research Reviews, 1996